Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production (Q40436594)

20 September 2017

title

Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production (English)

1 reference

20 September 2017

Chengwen Li

1 reference

20 September 2017

R Jude Samulski

series ordinal

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

335

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

10-21

1 reference

Characterization of the DNA of a defective human parvovirus isolated from a genital site

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Improving rAAV production and purification: towards the definition of a scaleable process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Replication competent helper functions for recombinant AAV vector generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Cell lines for the production of recombinant adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Quantitative analysis of the packaging capacity of recombinant adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Rep/Cap gene amplification and high-yield production of AAV in an A549 cell line expressing Rep/Cap.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Clades of Adeno-associated viruses are widely disseminated in human tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Novel tools for production and purification of recombinant adenoassociated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Advances in AAV-mediated gene transfer for the treatment of inherited disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Selective extraction of polyoma DNA from infected mouse cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Adeno-associated virus vectors can be efficiently produced without helper virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

AAV vectors: is clinical success on the horizon?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Genetic fate of recombinant adeno-associated virus vector genomes in muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Insect cells as a factory to produce adeno-associated virus type 2 vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Role for highly regulated rep gene expression in adeno-associated virus vector production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

7 January 2021

Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

7 January 2021

Nucleotide sequence and organization of the adeno-associated virus 2 genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.02.008

7 January 2021

10.1016/J.VIROL.2005.02.008

Identifiers

DOI

1 reference

20 September 2017

1 reference